FDA approves Xeljanz (tofacitinib) for rheumatoid arthritis

The FDA just announced the approval of Xeljanz (tofacitinib) for rheumatoid arthritis. Read more here.

We should see some interesting discussions about this given that the 2012 ACR/ARHP Annual Meeting is right around the corner.